Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of anti...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Ratcliffe, H, Tiley, K, Longet, S, Tonry, C, Roarty, C, Watson, C, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, PK, Galiza, E, Faust, SN, Hughes, S, Murray, C, Roderick, MR, Shackley, F, Oddie, S, Lee, TWR, Turner, DPJ, Raman, M, Owens, S, Turner, PJ, Cockerill, H, Lopez Bernal, J, Ijaz, S, Poh, J, Shute, J, Linley, E, Borrow, R, Hoschler, K, Brown, KE, Carroll, MW, Klenerman, P, Dunachie, SJ, Ramsay, M, Voysey, M, Waterfield, T, Snape, MD
Format:	Journal article
Sprog:	English
Udgivet:	Elsevier 2023

Lignende værker

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
af: Helen Ratcliffe, et al.
Udgivet: (2023-12-01)

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
af: Ratcliffe, H, et al.
Udgivet: (2022)

The Role of Intestinal Epithelial Permeability in Multisystem Inflammatory Syndrome in Children: A Case–Control Study
af: Cathal Roarty, et al.
Udgivet: (2024-08-01)

PANDEMIC HUMAN CORONAVIRUS – CHARACTERIZATION AND COMPARISON OF SELECTED PROPERTIES OF HCOV-SARS AND HCOV-MERS
af: Katarzyna W. Pancer
Udgivet: (2018-06-01)

Development of Primer Panels for Whole-Genome Amplification and Sequencing of Human Seasonal Coronaviruses: hCoV-OC43, hCoV-HKU1, hCoV-229E, and hCoV-NL63
af: Tamila Musaeva, et al.
Udgivet: (2024-12-01)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study [version 2; peer review: 2 approved]
af: Robert W. Aldridge, et al.
Udgivet: (2020-12-01)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
af: Virginia Fuochi, et al.
Udgivet: (2023-03-01)

Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China
af: Li-Jin Cui, et al.
Udgivet: (2011-01-01)

Seroconversion to HCoV-NL63 in Rhesus Macaques
af: Lia van der Hoek, et al.
Udgivet: (2009-10-01)

HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia
af: Lida Carolina Lesmes-Rodríguez, et al.
Udgivet: (2024-08-01)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
af: Sean A. Lynch, et al.
Udgivet: (2021-08-01)

The transcriptional and translational landscape of HCoV-OC43 infection.
af: Stefan Bresson, et al.
Udgivet: (2025-01-01)

Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
af: Yongkang Chen, et al.
Udgivet: (2022-04-01)

Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
af: Jiangchao Xiang, et al.
Udgivet: (2022-11-01)

55: DEVELOPMENT OF A NOVEL IN-VITRO HCOV-OC43 SCREENING METHOD
af: S. Haynes, et al.
Udgivet: (2022-11-01)

The human coronavirus HCoV-229E S-protein structure and receptor binding
af: Zhijie Li, et al.
Udgivet: (2019-10-01)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
af: Martin Dugas, et al.
Udgivet: (2021-04-01)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
af: Alvaro A. Ordonez, et al.
Udgivet: (2022-03-01)

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
af: Yongmei Feng, et al.
Udgivet: (2022-12-01)

Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19
af: Catherine LaCourse
Udgivet: (2024-12-01)

HCoV‐HKU1 and TMPRSS2 interaction: uncovering mechanisms of viral invasion
af: Zehan Pang, et al.
Udgivet: (2025-01-01)

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
af: Jang Hoon Kim, et al.
Udgivet: (2023-12-01)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
af: Sophie Steiner, et al.
Udgivet: (2020-12-01)

Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004
af: Theo P. Sloots, et al.
Udgivet: (2012-04-01)

Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
af: Yongmei Feng, et al.
Udgivet: (2024-12-01)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
af: Jing Yang, et al.
Udgivet: (2020-08-01)

Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry
af: Huan Sun, et al.
Udgivet: (2020-01-01)

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
af: Sébastien Pasquereau, et al.
Udgivet: (2021-02-01)

Disinfection Effect of High-pressure Carbon Dioxide on Human Coronavirus (hCoV-229E)
af: Peng NING, et al.
Udgivet: (2023-01-01)

A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
af: Peifang Xie, et al.
Udgivet: (2022-05-01)

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
af: Nehemya Friedman, et al.
Udgivet: (2018-09-01)

IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
af: Gianfranco Politano, et al.
Udgivet: (2020-09-01)

ESCRT Protein VPS4A Is Required for the Formation of Replication Centers and Replication of Human Coronavirus 229E (HCoV-229E)
af: Rinki Kumar, et al.
Udgivet: (2024-08-01)

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
af: Irene A. Abela, et al.
Udgivet: (2024-02-01)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
af: Darina Bačenková, et al.
Udgivet: (2021-02-01)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
af: Laura Thümmler, et al.
Udgivet: (2021-08-01)

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
af: Xiaohuan Wang, et al.
Udgivet: (2022-07-01)

Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes
af: Xiyong Song, et al.
Udgivet: (2021-01-01)

Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
af: Nehemya Friedman, et al.
Udgivet: (2021-01-01)

Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C
af: Tiley, KS, et al.
Udgivet: (2022)